Nanovaccine: Current Status
DOI:
https://doi.org/10.37285/ijpsn.2022.15.2.1Downloads
Metrics
Keywords:
nanovaccine, immune system, nanotechnology, infectious diseaseDownloads
Published
How to Cite
Issue
Section
References
Abbasi Kajani, A., Haghjooy Javanmard, S., Asadnia, M., & Razmjou, A. (2021). Recent Advances in Nanomaterials Development for Nanomedicine and Cancer. ACS Applied Bio Materials, 4(8), 5908–5925.
Ahmad, M. Z., Ahmad, J., Haque, A., Alasmary, M. Y., Abdel-Wahab, B. A., & Akhter, S. (2020). Emerging advances in synthetic cancer nano-vaccines: Opportunities and challenges. Expert Review of Vaccines, 19(11), 1053–1071.
Alphandéry, E. (2022). Nano dimensions/adjuvants in COVID-19 vaccines. Journal of Materials Chemistry B, 10(10), 1520–1552.
Constantin, C., Pisani, A., Bardi, G., & Neagu, M. (2021). Nano-carriers of COVID-19 vaccines: The main pillars of efficacy. Nanomedicine, 16(26), 2377–2387.
Gheibi Hayat, S. M., & Darroudi, M. (2019). Nanovaccine: A novel approach in immunization. Journal of Cellular Physiology, 234(8), 12530–12536.
Hallan, S. S., Sguizzato, M., Esposito, E., & Cortesi, R. (2021). Challenges in the Physical Characterization of Lipid Nanoparticles. Pharmaceutics, 13(4), 549.
Jiang, J. (2021). Cell-penetrating Peptide-mediated Nanovaccine Delivery. Current Drug Targets, 22(8), 896–912.
Koirala, P., Bashiri, S., Toth, I., & Skwarczynski, M. (2022). Current Prospects in Peptide-Based Subunit Nanovaccines. In S. Thomas (Ed.), Vaccine Design, Methods in Molecular Biology (Vol. 2412, pp. 309–338). New York, NY: Springer US. Retrieved April 25, 2022, from https://link.springer.com/10.1007/978-1-0716-1892-9_16
Pati, R., Shevtsov, M., & Sonawane, A. (2018). Nanoparticle Vaccines Against Infectious Diseases. Frontiers in Immunology, 9, 2224.
